When appetite drops, those three things can unravel fast, especially if meals feel heavier than usual or food becomes easy to forget
Clinical Evidence: Reduced Cardiovascular Events Major cardiovascular outcome trials demonstrate significant benefits: LEADER trial: Semaglutide reduced major adverse cardiovascular events (MACE) by 13% compared to placebo in type 2 diabetes patients
As more people discover their advantages, GLP-1s are being prescribed earlier in the treatment journey, often displacing longstanding first-line therapies like metformin
This platform offers a microenvironment and components similar to those of the actual tissue
The overall effect should be more consistent coverage options for eligible patients and fewer sudden out-of-pocket spikes, although timing and plan-level formularies will dictate individual access
How to Read These IU Values The IU column only works if your vial concentration matches the chart's assumption of 10mg/mL